Syncona Limited
2019 Dividend Scrip Reference Price
28 June 2019
Syncona Ltd announces that the scrip reference price for its 2019 dividend will be £2.281. This is the higher of (i) the prevailing average of the middle market quotations of its ordinary shares derived from the Daily Official List of the London Stock Exchange for the ex-dividend date, 20 June 2019, and the four subsequent dealing days and (ii) the net asset value per ordinary share as at 31 March 2019.
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver / Annabel Clay
Tel : +44 (0) 20 3981 7940
FTI Consulting
Brett Pollard / Natalie Garland-Collins
Tel: +44 (0) 20 3727 1000
Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com
About Syncona
Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.
